MSE
VRTX icon

MUFG Securities EMEA’s Vertex Pharmaceuticals VRTX Stock Holding History

MUFG Securities EMEA’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.65M Buy
10,413
+12
+0.1% +$5.6K 0.07% 178
2025
Q4 		$4.72M Buy
10,401
+5,494
+112% +$2.37M 0.05% 203
2025
Q3 		$1.92M Buy
4,907
+4,150
+548% +$1.73M 0.05% 167
2025
Q2 		$337K Buy
+757
New +$349K 0.01% 159
2024
Q4 		– Sell
-21,000
Closed -$9.77M – 225
2024
Q3 		$9.77M Buy
+21,000
New +$10.1M 0.35% 81
2020
Q3 		– Sell
-50,496
Closed -$14.7M – 473
2020
Q2 		$14.7M Buy
+50,496
New +$13.7M 0.13% 127
2020
Q1 		– Sell
-10,000
Closed -$2.19M – 542
2019
Q4 		$2.19M Buy
+10,000
New +$2.02M 0.02% 374
2019
Q3 		– Sell
-54,400
Closed -$9.98M – 447
2019
Q2 		$9.98M Buy
54,400
+25,400
+88% +$4.44M 0.11% 133
2019
Q1 		$5.33M Buy
+29,000
New +$5.36M 0.06% 192
2018
Q4 		– Sell
-6,928
Closed -$1.33M – 719
2018
Q3 		$1.33M Buy
6,928
+6,643
+2,331% +$1.18M 0.02% 280
2018
Q2 		$48K Sell
285
-39,715
-99% -$6.16M ﹤0.01% 305
2018
Q1 		$6.52M Hold
40,000
– – 0.14% 115
2017
Q4 		$5.99M Hold
40,000
– – 0.14% 97
2017
Q3 		$6.08M Buy
+40,000
New +$6.02M 0.22% 63

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MUFG Securities EMEA's VRTX Position: Q1 2026 in Review

MUFG Securities EMEA increased its Vertex Pharmaceuticals (VRTX) stake by 0.12% in Q1 2026, buying an estimated $5.6K and bringing the position to 10,413 shares worth $4.65M. The position accounts for 0.07% of the portfolio, ranked #178.

MUFG Securities EMEA first reported a position in VRTX in Q3 2017 and has held it in 14 quarters since. The position peaked at $14.7M in Q2 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • MUFG Securities EMEA held 10,413 shares of Vertex Pharmaceuticals worth $4.65M as of Q1 2026.
  • MUFG Securities EMEA bought 12 Vertex Pharmaceuticals shares in Q1 2026, an estimated $5.6K.
  • Vertex Pharmaceuticals made up 0.07% of MUFG Securities EMEA's portfolio in Q1 2026, its #178 holding.
  • MUFG Securities EMEA first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 14 quarters since.
  • MUFG Securities EMEA's Vertex Pharmaceuticals position peaked at $14.7M in Q2 2020.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.